Advanced in Hemangioendothelioma

Rossella M. Bertulli

Milan, IT 
Advanced in Hemangioendothelioma
Milan, IT 
OverviewLocationsClinical Research

Overview

Rossella Bertulli practices in Milan, Italy. Ms. Bertulli is rated as an Advanced expert by MediFind in the treatment of Hemangioendothelioma. Her top areas of expertise are Adult Soft Tissue Sarcoma, Osteosarcoma, Ewing Sarcoma, and Hemangioendothelioma.

Her clinical research consists of co-authoring 47 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Female

Locations

Milan, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma - Prospective Study (ISG/OS-2)
ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma - Prospective Study (ISG/OS-2)
Enrollment Status: Completed
Publish Date: May 20, 2024
Intervention Type: Other, Drug
Study Drug: Mifamurtide
Study Phase: Phase 2
Study With High Doses of Chemotherapy, Radiotherapy and Consolidation Therapy With Ciclofosfamide and Anticyclooxygenase 2, for the Metastatic Ewing Sarcoma
Study With High Doses of Chemotherapy, Radiotherapy and Consolidation Therapy With Ciclofosfamide and Anticyclooxygenase 2, for the Metastatic Ewing Sarcoma
Enrollment Status: Completed
Publish Date: September 19, 2022
Intervention Type: Drug
Study Drugs: TEMIRI, ADM, IFO, CYC, ETO, BUMEL, VIN
Study Phase: Phase 2
Multicentric, Randomized Phase II Trial for the Treatment of Patients With Relapsed Osteosarcoma
Multicentric, Randomized Phase II Trial for the Treatment of Patients With Relapsed Osteosarcoma
Enrollment Status: Terminated
Publish Date: May 13, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

47 Total Publications

Intensified Induction Therapy for Newly Diagnosed, Localized Skeletal Ewing Sarcoma (ISG/AIEOP EW-1): A Randomized, Open-Label, Phase 3, Non-Inferiority Trial.
Intensified Induction Therapy for Newly Diagnosed, Localized Skeletal Ewing Sarcoma (ISG/AIEOP EW-1): A Randomized, Open-Label, Phase 3, Non-Inferiority Trial.
Journal: Pediatric blood & cancer
Published: October 04, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Bertulli's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 18 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile